Synthetic lethal strategies to limit tumor evolution driven by APOBEC3 activity in urothelial cancer Grant uri icon

Overview

date/time interval

  • July 1, 2022 - June 30, 2023

sponsor award ID

  • BCAN 223355-01

Affiliation